Jump to content
CONCORD, California – (Business Wire) – March 9, 2007: Concord-based Xradia Inc. announced the closing of a $7million equity in a series D financing round. Major investors included Harris & Harris Group Inc., an unnamed strategic investor, and a prior round investor. Xradia designs, manufactures and sells a suite of ultrahigh-resolution 3-D X-ray microscopes and fluorescence imaging systems. Applications include 3-D imaging for the semiconductor industry as biological specimens ranging from single cells to small animals.
Xradia, Inc. is a privately held company established in 2000 to commercialize high-resolution 3D X-ray microscopes for nondestructive inspection and nano-scale imaging. Initially targeted at failure analysis in the semiconductor IC industry, subsequent developments have led to a suite of commercial X-ray imaging products that have permitted expansion into markets that include basic research, metrology in semiconductor IC production, biomedical research and nanotechnology development. These advanced systems offer outstanding nondestructive imaging capabilities. These include nanometer resolution 3D imaging of complex objects, such as IC chips and biological specimens and element-specific imaging for process control and monitoring in IC manufacturing. The company also supplies advanced X-ray imaging components and state of the art imaging systems to the synchrotron research community. The company is rapidly expanding in 2005 in response to growing demand for its unique X-ray imaging products.